Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Tebrophen—An Old Polyphenol Drug with Anticancer Potential (CROSBI ID 178541)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Rubelj, Ivica ; Stepanić, Višnja ; Jelić, Dubravko ; Škrobot Vidaček, Nikolina ; Ćukušić Kalajžić, Andrea ; Ivanković, Milena ; Nujić, Krunoslav ; Matijašić, Mario ; Verbanac, Donatella Tebrophen—An Old Polyphenol Drug with Anticancer Potential // Molecules, 17 (2012), 7; 7864-7886. doi: 10.3390/molecules17077864

Podaci o odgovornosti

Rubelj, Ivica ; Stepanić, Višnja ; Jelić, Dubravko ; Škrobot Vidaček, Nikolina ; Ćukušić Kalajžić, Andrea ; Ivanković, Milena ; Nujić, Krunoslav ; Matijašić, Mario ; Verbanac, Donatella

engleski

Tebrophen—An Old Polyphenol Drug with Anticancer Potential

In vitro high-throughput screening was carried out in order to detect new activities for old drugs and to select compounds for the drug development process comprising new indications. Tebrophen, a known antiviral drug, was found to inhibit activities on inflammation and cancer related targets. In primary screening this semisynthetic halogenated polyphenol was identified to inhibit the activities of kinases ZAP-70 and Lck (IC50 0.34 μM and 16 μM, respectively), as well as hydrolase DPPIV (at 80 μM 41% inhibition). Next, it showed no cytotoxic effects on standard cell lines within 24 h. However, tebrophen slowed propagation of breast cancer (MDA-MB-231), osteosarcoma (U2OS) and cervical carcinoma (HeLa), through at least 35 population doublings in a dose-dependent manner. It completely stopped the division of the prostate cancer (PC3) cell line at 50 μM concentration and the cells entered massive cell death in less than 20 days. On the other hand, tebrophen did not influence the growth of normal fibroblasts. According to the measured oxidative burst and estimated in silico parameters its direct antioxidative ability is limited. The obtained results indicate that tebrophen can be considered a promising lead molecule for generating more soluble derivatives with specific anticancer efficacy.

tebrophen; anticancer; high-throughput screening; molecular modeling; population doublings

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

17 (7)

2012.

7864-7886

objavljeno

1420-3049

10.3390/molecules17077864

Povezanost rada

Kemija, Temeljne medicinske znanosti, Biologija

Poveznice
Indeksiranost